Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

(177)Lu-lilotomab satetraxetan MeSH Supplementary Concept Data 2025


MeSH Supplementary
(177)Lu-lilotomab satetraxetan
Unique ID
C000631206
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000631206
Pharm Action
Radiopharmaceuticals
Registry Numbers
0
Heading Mapped to
*Antibodies, Monoclonal
Frequency
5
Note
177Lu-lilotomab satetraxetan is a novel antibody–radionuclide conjugate that targets CD37
Source
J Nucl Med. 2018 Apr;59(4):704-710.
Date of Entry
2019/05/16
Revision Date
2019/05/20
(177)Lu-lilotomab satetraxetan Preferred
page delivered in 0.006s